Format

Send to

Choose Destination
Ann Med. 2016;48(1-2):89-102. doi: 10.3109/07853890.2015.1137630. Epub 2016 Jan 30.

Metabolomics in diabetes, a review.

Author information

1
a Instituto Nacional De Ciencias Médicas Y Nutrición "Salvador Zubirán" , Ciudad De México , D.F ;
2
b Instituto Nacional De Medicina Genómica , Tlalpan , Ciudad De México , D.F.

Abstract

Metabolomics is a promising approach for the identification of chemical compounds that serve for early detection, diagnosis, prediction of therapeutic response and prognosis of disease. Moreover, metabolomics has shown to increase the diagnostic threshold and prediction of type 2 diabetes. Evidence suggests that branched-chain amino acids, acylcarnitines and aromatic amino acids may play an early role on insulin resistance, exposing defects on amino acid metabolism, β-oxidation, and tricarboxylic acid cycle. This review aims to provide a panoramic view of the metabolic shifts that antecede or follow type 2 diabetes. Key messages BCAAs, AAAs and acylcarnitines are strongly associated with early insulin resistance. Diabetes risk prediction has been improved when adding metabolomic markers of dysglycemia to standard clinical and biochemical factors.

KEYWORDS:

Acylcarnitines; aromatic amino acids; branched-chain amino acids; diabetes; dysglycemia; insulin resistance; mass spectrometry; metabolomics; nuclear magnetic resonance spectroscopy; obesity

PMID:
26883715
DOI:
10.3109/07853890.2015.1137630
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center